Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 209241

Expand all

INGREZZA (VALBENAZINE TOSYLATE)
EQ 40MG BASE
Marketing Status: Prescription
Active Ingredient: VALBENAZINE TOSYLATE
Proprietary Name: INGREZZA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 40MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N209241
Product Number: 001
Approval Date: Apr 11, 2017
Applicant Holder Full Name: NEUROCRINE BIOSCIENCES INC
Marketing Status:  Prescription
Patent and Exclusivity Information
INGREZZA (VALBENAZINE TOSYLATE)
EQ 60MG BASE
Marketing Status: Prescription
Active Ingredient: VALBENAZINE TOSYLATE
Proprietary Name: INGREZZA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 60MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N209241
Product Number: 003
Approval Date: Apr 23, 2021
Applicant Holder Full Name: NEUROCRINE BIOSCIENCES INC
Marketing Status:  Prescription
Patent and Exclusivity Information
INGREZZA (VALBENAZINE TOSYLATE)
EQ 80MG BASE
Marketing Status: Prescription
Active Ingredient: VALBENAZINE TOSYLATE
Proprietary Name: INGREZZA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: EQ 80MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N209241
Product Number: 002
Approval Date: Oct 4, 2017
Applicant Holder Full Name: NEUROCRINE BIOSCIENCES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English